Boundless Bio Inc (BOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 39,057 | 37,089 | 72,788 | 45,649 |
| Marketable Securities | 94,638 | 68,524 | 23,169 | 14,851 |
| TOTAL | $137,010 | $108,437 | $99,639 | $60,941 |
| Non-Current Assets | ||||
| PPE Net | 24,372 | 18,936 | 2,968 | 264 |
| Investments And Advances | 0 | 0 | 0 | 1,698 |
| Intangibles | 11,631 | 11,631 | 11,631 | 0 |
| Other Non-Current Assets | 5,649 | 3,053 | 3,231 | 106 |
| TOTAL | $41,652 | $33,620 | $17,830 | $2,068 |
| Total Assets | $178,662 | $142,057 | $117,469 | $63,009 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 8,496 | 2,424 | 2,789 | 1,240 |
| Accrued Expenses | 8,832 | 9,871 | 4,797 | 1,871 |
| TOTAL | $17,712 | $12,560 | $7,723 | $3,111 |
| Non-Current Liabilities | ||||
| Deferred Revenues | 384 | 265 | 137 | N/A |
| Other Non-Current Liabilities | 60 | 4,380 | 4,278 | 0 |
| TOTAL | $4,352 | $10,126 | $8,057 | $34 |
| Total Liabilities | $22,064 | $22,686 | $15,780 | $3,145 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 36,674 | 21,889 | N/A | N/A |
| Retained earnings | -190,649 | -100,411 | -40,743 | -14,285 |
| Other shareholders' equity | -80 | -29 | 135,740 | 72,393 |
| TOTAL | $156,598 | $119,371 | $101,689 | $59,864 |
| Total Liabilities And Equity | $178,662 | $142,057 | $117,469 | $63,009 |